{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:40:36Z","timestamp":1790404836141,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T00:00:00Z","timestamp":1718409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.kint.2024.05.006","type":"journal-article","created":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T11:52:06Z","timestamp":1716637926000},"page":"408-418","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Evaluation of glomerular hemodynamic changes by sodium-glucose-transporter 2 inhibition in type 2 diabetic rats using in\u00a0vivo imaging"],"prefix":"10.1016","volume":"106","author":[{"given":"Yoshihisa","family":"Wada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4932-0166","authenticated-orcid":false,"given":"Kengo","family":"Kidokoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuyuki","family":"Tokuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kadoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Nagasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichiro","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamaki","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Z.I.","family":"Cherney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Kashihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2024.05.006_bib1","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2024.05.006_bib2","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2024.05.006_bib3","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1161\/CIRCULATIONAHA.118.037418","article-title":"Evaluation of glomerular hemodynamic function by empagliflozin in diabetic mice using in\u00a0vivo imaging","volume":"140","author":"Kidokoro","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2024.05.006_bib4","doi-asserted-by":"crossref","first-page":"F495","DOI":"10.1152\/ajprenal.00521.2005","article-title":"Quantitative imaging of basic functions in renal (patho)physiology","volume":"291","author":"Kang","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2024.05.006_bib5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.mam.2016.11.002","article-title":"Insulin\/adenosine axis linked signalling","volume":"55","author":"Silva","year":"2017","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.kint.2024.05.006_bib6","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/21224","article-title":"Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation","volume":"399","author":"Dimmeler","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.kint.2024.05.006_bib7","doi-asserted-by":"crossref","first-page":"30392","DOI":"10.1074\/jbc.M103702200","article-title":"Insulin-stimulated activation of eNOS is independent of Ca2+ but requires phosphorylation by Akt at Ser(1179)","volume":"276","author":"Montagnani","year":"2001","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.kint.2024.05.006_bib8","first-page":"1011539","article-title":"Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells","author":"Zeng","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2024.05.006_bib9","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1210\/me.2002-0074","article-title":"Insulin receptor substrate-1 and phosphoinositide-dependent kinase-1 are required for insulin-stimulated production of nitric oxide in endothelial cells","volume":"16","author":"Montagnani","year":"2002","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.kint.2024.05.006_bib10","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.12895","article-title":"Hyperinsulinemia augments endothelin-1 protein expression and impairs vasodilation of human skeletal muscle arterioles","volume":"4","author":"Mahmoud","year":"2016","journal-title":"Physiol Rep"},{"key":"10.1016\/j.kint.2024.05.006_bib11","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/sj.bjp.0706042","article-title":"Endothelium-dependent contractions in hypertension","volume":"144","author":"Vanhoutte","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.kint.2024.05.006_bib12","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1161\/CIRCRESAHA.116.303604","article-title":"The sympathetic nervous system alterations in human hypertension","volume":"116","author":"Grassi","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.kint.2024.05.006_bib13","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1172\/JCI115842","article-title":"Abnormal sympathetic overactivity evoked by insulin in the skeletal muscle of patients with essential hypertension","volume":"90","author":"Lembo","year":"1992","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2024.05.006_bib14","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/jcp.20680","article-title":"Nitric oxide reduces adenosine transporter ENT1 gene (SLC29A1) promoter activity in human fetal endothelium from gestational diabetes","volume":"208","author":"Far\u00edas","year":"2006","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.kint.2024.05.006_bib15","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.kint.2019.09.013","article-title":"The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes\u00a0in the randomized, double-blind RED trial","volume":"97","author":"van Bommel","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2024.05.006_bib16","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12933-021-01358-8","article-title":"Renal hemodynamic effects differ between antidiabetic combination strategies: randomized controlled clinical trial comparing empagliflozin\/linagliptin with metformin\/insulin glargine","volume":"20","author":"Ott","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.kint.2024.05.006_bib17","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1152\/physrev.00031.2005","article-title":"Adenosine and kidney function","volume":"86","author":"Vallon","year":"2006","journal-title":"Physiol Rev"},{"key":"10.1016\/j.kint.2024.05.006_bib18","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1152\/physrev.1996.76.2.425","article-title":"Paracrine regulation of the renal microcirculation","volume":"76","author":"Navar","year":"1996","journal-title":"Physiol Rev"},{"key":"10.1016\/j.kint.2024.05.006_bib19","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1124\/pr.59.3.3","article-title":"The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease","volume":"59","author":"Kobori","year":"2007","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.kint.2024.05.006_bib20","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s001250051259","article-title":"Glomerular hypertension as one cause of albuminuria in type II diabetic patients","volume":"42","author":"Imanishi","year":"1999","journal-title":"Diabetologia"},{"key":"10.1016\/j.kint.2024.05.006_bib21","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1152\/physrev.1998.78.3.723","article-title":"Glomerular mesangial cells: electrophysiology and regulation of contraction","volume":"78","author":"Stockand","year":"1998","journal-title":"Physiol Rev"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253824003405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253824003405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T20:39:06Z","timestamp":1728333546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253824003405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0085253824003405"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2024.05.006","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of glomerular hemodynamic changes by sodium-glucose-transporter 2 inhibition in type 2 diabetic rats using in\u00a0vivo imaging","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2024.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2024.06.018","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}